Search Press releases Keywords From To 23 Apr 2021 The New England Journal of Medicine Publishes Results from Two Bimekizumab Phase 3 Studies in Moderate to Severe Plaque Psoriasis Read More 22 Apr 2021 UCB’s zilucoplan shows no relevant effect in immune-mediated necrotizing myopathy (IMNM) Read More 20 Apr 2021 Acquisitions of own shares and Disposals of own shares Read More 16 Apr 2021 UCB showcases new research at the 73rd American Academy of Neurology Annual Meeting to demonstrate broad neurology leadership and future portfolio Read More 14 Apr 2021 Notice of Early Redemption - €350 million € 1.875% fixed rate notes due 2 April 2022 Read More 9 Apr 2021 Acquisitions of own shares and Disposals of own shares Read More Pagination First page Previous page Previous … Page 42 Page 43 Page 44 Page 45 Current page 46 Page 47 Page 48 Page 49 Page 50 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
